The Clinical Healthcare Continuum

Recent years have seen an explosion of innovation in health care and life sciences. In 2023, the FDA approved the world’s first CRISPR therapy to treat sickle cell disease and a new treatment for Alzheimer’s disease. The advent of generative AI, digital devices and wearables has also opened new frontiers, driving advancements that redefine how we approach, develop and experience medical care.
Panel: The Clinical Healthcare Continuum
Dr. Sam Ajizian, CMO, Medtronic Patient Monitoring
Dr. John Desjarlais, EVP and Chief Scientific Officer, Xencor
Dr. Daniel Oh, Associate Medical Officer, Intuitive Surgical
Read more about the UCLA Anderson Healthcare Business Association’s annual Vitals conference:
www.anderson.ucla.edu/about/c...
#medtech #therapeutics #biotech